MedAdNews
July, 2006
Most Recognized Dermatology Brands
The most –recognized dermatology brand in north American is Retin – A, according to a study done by Brand Institute Inc. In fourth – quarter 2005. About 7.5% of physicians recognized this brand the most. Retin – A contains tretinoin and is indicated for the treatment of acne vulgaris. The product is marketed by Orthoneutrogena (orthoneutrogena.com), which is owned by Johnson & Johnson (jnj.com)
Elidel was the second most – recognize dermatology brand in North America, with 5.6% of physicians recognizing this brand the most. Composed of pimecrolimus, Elidel is indicated for the short-term and intermittent long-term of mild to moderate atopic dermatitis in nonimmunocompromised patients 2 year old or older. The product is marketed by Novartis (norvartis.com)
The third most-recognized cardiovascular brand in the United States is Coreg. About 5% of physicians recognize this brand the most. Coreg is indicated for the treatment of mild-to-moderate congestive heart failure in children 1 month old to 18 years old, the treatment of mild-to-severe heart failure or ischemic or cardiomyopathic origin, the essential hypertension, the treatment of severe heart failure, and to reduce cardiovascular mortality. Coreg contains carvedilol and initially was approved by FDA in September 1995. The product is marketed by GlaxoSmithKline (gsk.com).
The third most recognized dermatology brand in North America is Accutane. About 5.1% of physicians recognize this brand the most. Accutane marketed by Roche (roche.com) and containing isotretinoin, is indicated for the treatment of severe nodular acne.
Develop Brand
Betnovate is the most –recognized dermatology brand in Europe. About 5.4 % of physicians recognize this brand the most. Betnovate comprises betamethasone and indicated for the treatment of eczema, prurigo nodularis, psoriasis, neurodermatoses, contact – sensitivity reactions, and discoid lupus erythematosus, and may be used as an adjunct to systemic steroid therapy in generalized erythroderma. The product is marketed by Glaxosmithkline (gsk.com)
The product second most –recognized brand in Europe is loprox. About 4.6% of physicians recognize this brand the most. Loprox is composed of ciclopirox and is marketed by Medicis pharmaceuticals Corp. (medicis.com). The product is indicated for the treatment of superficial dermatophyte infections, seborrheic dermatitis of the scalp, tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, tinea vericolor, athlete’s foot, jock itch and ringworm.
Dermovate is the third most –recognized dermatology brand in Europe.3.6% of physicians recognize this brand the most. Composed of clobetasol, dermovate is indicated for the treatment of psoriasis, recalcitrant eczemas, lichen planus, and discoid lupus erythematosus. The product is known as Temovate in the United States and is marketed by glaxosmithkline.
Brand Institute (Brand Institute.com) surveyed more than 2,000 physicians and hospital and retail pharmacists in North America and Europe to determine the most- recognizable brands in the category of dermatology drugs. Brand poll is a marketing tool that is designed to help client monitor the competitive market place and identify the potential strengths and weaknesses of their brand.
Develop Brand
